Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >ATI-2341 acetate(1337878-62-2 free base)
ATI-2341 acetate(1337878-62-2 free base)
  • ATI-2341 acetate(1337878-62-2 free base)

ATI-2341 acetate(1337878-62-2 free base) NEW

Price $55 $189 $279
Package 1mg 5mg 10mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-09-18

Product Details

Product Name: ATI-2341 acetate(1337878-62-2 free base) Purity: 97.14%
Supply Ability: 10g Release date: 2025/09/18

Product Introduction

Bioactivity

NameATI-2341 acetate(1337878-62-2 free base)
DescriptionATI-2341 acetate is an effective allosteric agonist of CXCR4, it activates Gα1 instead of Gα13. ATI-2341 acetate activates inhibitory heterotrimeric G protein (GI) to promote the inhibition of cAMP production and induce calcium mobilization.
In vitroATI-2341 induced CXCR4- and G protein-dependent signaling, receptor internalization, and chemotaxis in CXCR4-expressing cells[1].
In vivoATI-2341 induced dose-dependent peritoneal recruitment of PMNs when administered i.p. to mice. When administered systemically by i.v. bolus, ATI-2341 acted as a functional antagonist and dose-dependently mediated release of PMNs from the bone marrow of both mice and cynomolgus monkeys[1].
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationDMSO : Slightly soluble
KeywordsCXCR4 | ATI-2341 acetate(1337878-62-2 free base) | ATI2341 acetate(1337878622 free base) | ATI 2341 acetate(1337878 62 2 free base)
Inhibitors RelatedAZD8309 | rac-NBI-74330 | Delmetacin | Tannic acid | Artemotil | CXCR2-IN-1 | LIT927 | Plerixafor octahydrochloride | SX-682 | Nicotinamide N-oxide | Plerixafor | CXCL-CXCR1/2-IN-1
Related Compound LibrariesMembrane Protein-targeted Compound Library | Peptide Compound Library | NO PAINS Compound Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$76.00/1mg
VIP4Y
TargetMol Chemicals Inc.
2025-09-18
$0.00/1kg
VIP6Y
Zison Pharmaceutical (Shandong) Co., Ltd.
2024-05-24
$0.00/25KG
VIP1Y
Shaanxi Dideu New Materials Co. Ltd
2025-05-16

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY